Aripiprazole complex formulation and method
First Claim
Patent Images
1. An aqueous injectable formulation comprisinga) a complex comprising aripiprazole and sulfobutyl ether-β
- -cyclodextrin;
b) tartaric acid;
c) sodium hydroxide; and
d) water for injection.
1 Assignment
0 Petitions
Accused Products
Abstract
An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided.
55 Citations
8 Claims
-
1. An aqueous injectable formulation comprising
a) a complex comprising aripiprazole and sulfobutyl ether-β - -cyclodextrin;
b) tartaric acid; c) sodium hydroxide; and d) water for injection. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
- -cyclodextrin;
Specification